End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.03 CNY | -6.51% | -10.95% | -25.19% |
04-26 | Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-13 | JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.19% | 845M | - | ||
-32.10% | 10.8B | B | ||
-10.85% | 7.31B | B | ||
+9.89% | 6.19B | C | ||
-11.53% | 5.89B | C+ | ||
+73.65% | 4.79B | C | ||
-4.09% | 4.58B | D- | ||
-8.36% | 3.75B | B | ||
-20.92% | 3.14B | C- | ||
-13.87% | 2.82B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 605266 Stock
- Ratings Jianzhijia Pharmaceutical Chain Group Co., Ltd.